Abstract
Aims: This study assessed the use of systolic time intervals (STI) as a potential non-invasive marker of the haemodynamic effects of sumatriptan, a 5HT1 receptor agonist. Methods: Twenty-six patients undergoing diagnostic cardiac catheterization participated. STIs were derived from haemodynamic pressure tracings at baseline, following placebo injection and following either subcutaneous (n = 18) or intravenous injection (n = 8) of sumatriptan. Results: Sumatriptan (i.v. or s.c.) was associated with significant increases in mean arterial pressure (95% C.I. 9,14 mmHg, P = 0.0001), total electromechanical systole (95% C.I. 8,36 ms, P < 0.0001), pre-ejection period (95% C.I. 8,21 ms, P = 0.0001) and left ventricular ejection time (95% C.I. 2,12 ms, P = 0.004). Conclusion: STI responses were consistent with sumatriptan-induced changes in afterload. In summary, the measurement of STIs is a potential non-invasive method of investigating the influence of serotonergic compounds on the cardiovascular system.
Author supplied keywords
Cite
CITATION STYLE
Hood, S., Birnie, D., Murray, L. S., MacIntyre, P. D., & Hillis, W. S. (1999). Changes in systolic time intervals: A non-invasive marker for the haemodynamic effects of sumatriptan. British Journal of Clinical Pharmacology, 48(3), 331–335. https://doi.org/10.1046/j.1365-2125.1999.00121.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.